New treatment aims to free hepatitis b patients from daily pills
NCT ID NCT07069569
Summary
This study is testing whether adding an experimental injection called AHB-137 to standard hepatitis B treatments can help patients eventually stop their daily antiviral pills. The research involves 127 adults with a specific type of chronic hepatitis B who are already taking antiviral medication. Doctors will check if the combination treatment reduces virus levels enough that patients can safely discontinue their long-term therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.